Trials / Sponsors / Todd C. Lee MD MPH FIDSA
Todd C. Lee MD MPH FIDSA
Academic / Other · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bloodstream Infection | Phase 4 | 2026-01-15 |
| Recruiting | Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia Pneumocystis, Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection | Phase 3 | 2025-11-28 |
| Recruiting | Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus Staphylococcus Aureus Endocarditis, Prosthetic Valve Endocarditis | Phase 3 | 2025-11-10 |
| Recruiting | Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia | Phase 4 | 2024-11-14 |
| Recruiting | Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis | Phase 2 | 2024-05-20 |